MedTrace Logo

Questionnaire and Laboratory Data on Vitiligo Vulgaris

NCT01206374 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 57

Last updated 2015-05-25

No results posted yet for this study

Summary

Vitiligo vulgaris is an autoimmune disorder that causes loss of pigmentation over the skin, hair and mucous membranes (e.g. lips, nose, genitals). While genes have been identified that are thought to be required for development of vitiligo, only 5-10% of relatives develop disease. The triggers for disease onset have not yet been identified. The intent of this study is to research trends in laboratory data, social and medical history that may be contributory to vitiligo onset, location of disease, course of illness and response to therapy.

Conditions

  • Vitiligo Vulgaris

Sponsors & Collaborators

  • Beth Israel Medical Center

    collaborator OTHER

  • St. Luke's-Roosevelt Hospital Center

    lead OTHER

Principal Investigators

  • Nanette Silverberg, MD · StLukesNY

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2010-10-31
Completion
2014-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01206374 on ClinicalTrials.gov